Embla Medical hf. (OSSFF)

4.5001 0.0000 (0.00%) At close: 10:30AM EDT

Embla Medical hf.

Grjótháls 1-5
Reykjavik
Iceland
354 515 1300
https://www.ossur.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 4,000

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Sveinn Solvason	President & CEO	1.07M	N/A	1978
Mr. Ossur Kristinsson	Founder	25k	N/A	1943
Ms. Gudny Arna Sveinsdottir	Chief Financial Officer	N/A	N/A	1966
Mr. Lukas Marklin	Chief Operating Officer	N/A	N/A	1974
Edda Lara Luovigsdottir	Investor Relations Director	N/A	N/A	N/A
Ms. Margret Lara Fridriksdottir	Executive Vice President of People, Strategy & Sustainability	237k	N/A	1978
Mr. Olafur Gylfason	Chief Commercial Officer	539k	N/A	1969
Mr. Gudjon G. Karason	Executive Vice President of EMEA & APAC	N/A	N/A	1969
Mr. Christian Robinson	President of Americas	N/A	N/A	1982
Ms. Hildur Einarsdottir	Executive Vice President of Research & Development	N/A	N/A	1982

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands for therapeutic and preventative purposes; and injury solutions for people recovering from fractures and ligament injuries. The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.

Corporate Governance

Embla Medical hf.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.